Wealthspire Advisors, L.P. - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 143 filers reported holding ALBANY MOLECULAR RESH INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$18,000
-76.0%
1,317
-67.0%
0.00%
-72.7%
Q4 2016$75,000
+11.9%
3,993
-1.4%
0.01%
+10.0%
Q3 2016$67,000
+39.6%
4,048
+12.9%
0.01%
+25.0%
Q2 2016$48,000
+29.7%
3,585
+50.1%
0.01%
+14.3%
Q1 2016$37,000
-11.9%
2,388
+11.7%
0.01%
-12.5%
Q4 2015$42,0002,1370.01%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q1 2017
NameSharesValueWeighting ↓
Permian Investment Partners, LP 3,338,892$62,638,0009.46%
Healthcare Value Capital, LLC 302,400$5,673,0006.08%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 1,753,303$32,892,0003.15%
AMERICAN CAPITAL MANAGEMENT INC 1,379,517$25,880,0002.00%
Netols Asset Management, Inc. 403,999$7,579,0001.56%
Walthausen & Co., LLC 716,855$13,448,0001.25%
RICE HALL JAMES & ASSOCIATES, LLC 1,261,934$23,674,0001.19%
AMI ASSET MANAGEMENT CORP 802,729$15,059,0001.11%
Evercore Wealth Management, LLC 1,052,441$19,744,0000.82%
MOODY ALDRICH PARTNERS LLC 65,047$1,220,0000.79%
View complete list of ALBANY MOLECULAR RESH INC shareholders